Intra-Cellular Therapies, Inc. Insider Trading for December 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intra-Cellular Therapies, Inc. for December 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.50 | 3,750 | 5,625 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.50 | 10,000 | 15,000 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.36 | 5,000 | 6,800 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.28 | 1,875 | 28,644 | 9,375 | 11.3 K to 9.4 K (-16.67 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.50 | 3,750 | 5,625 | 11,250 | 7.5 K to 11.3 K (+50.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.19 | 5,000 | 75,973 | 7,500 | 12.5 K to 7.5 K (-40.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.50 | 10,000 | 15,000 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.26 | 2,500 | 38,156 | 2,500 | 5 K to 2.5 K (-50.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.36 | 5,000 | 6,800 | 5,000 | 0 to 5 K |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |